Schroder Investment Management Group Portfolio holdings
AUM
$118B
1-Year Return
26.33%
This Quarter Return
+16.28%
1 Year Return
+26.33%
3 Year Return
+110.68%
5 Year Return
+193.29%
10 Year Return
+454%
AUM
$118B
AUM Growth
+$19.3B
(+19%)
Cap. Flow
+$7.38B
Cap. Flow
% of AUM
6.24%
Top 10 Holdings %
Top 10 Hldgs %
30.96%
Holding
1,256
New
68
Increased
498
Reduced
525
Closed
100
Top Buys
| 1 |
Microsoft
MSFT
|
$1.1B |
| 2 |
Monster Beverage
MNST
|
$447M |
| 3 |
NVIDIA
NVDA
|
$425M |
| 4 |
Netflix
NFLX
|
$363M |
| 5 |
Colgate-Palmolive
CL
|
$343M |
Top Sells
| 1 |
Trip.com Group
TCOM
|
$462M |
| 2 |
lululemon athletica
LULU
|
$353M |
| 3 |
UnitedHealth
UNH
|
$293M |
| 4 |
Spotify
SPOT
|
$260M |
| 5 |
Procter & Gamble
PG
|
$201M |
Sector Composition
| 1 | Technology | 30.09% |
| 2 | Communication Services | 13.6% |
| 3 | Financials | 13.17% |
| 4 | Consumer Discretionary | 11.14% |
| 5 | Healthcare | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Watsco
WSO
$16.6B
| $1.16M | ﹤0.01% |
2,627
-2,340
| -47% | -$1.03M |
|
952
Syndax Pharmaceuticals
SNDX
$1.47B
| $1.14M | ﹤0.01% |
122,163
+64,598
| +112% | +$605K |
|
953
Loews
L
$20B
| $1.13M | ﹤0.01% |
12,296
-3,465
| -22% | -$318K |
|
954
Rhythm Pharmaceuticals
RYTM
$6.78B
| $1.11M | ﹤0.01% |
17,618
| – | – |
|
955
Zimmer Biomet
ZBH
$20.9B
| $1.1M | ﹤0.01% |
12,011
-2,049
| -15% | -$187K |
|
956
LPL Financial
LPLA
$26.6B
| $1.09M | ﹤0.01% |
2,906
-619
| -18% | -$232K |
|
957
ASML
ASML
$307B
| $1.08M | ﹤0.01% |
1,347
+593
| +79% | +$475K |
|
958
iShares MSCI Australia ETF
EWA
$1.53B
| $1.07M | ﹤0.01% |
40,863
-44,500
| -52% | -$1.16M |
|
959
Applied Industrial Technologies
AIT
$10B
| $1.06M | ﹤0.01% |
4,563
+165
| +4% | +$38.4K |
|
960
RLI Corp
RLI
$6.16B
| $1.03M | ﹤0.01% |
14,239
-1,827
| -11% | -$132K |
|
961
Hologic
HOLX
$14.8B
| $1.03M | ﹤0.01% |
15,758
+210
| +1% | +$13.7K |
|
962
Fabrinet
FN
$13.2B
| $999K | ﹤0.01% |
3,389
-553
| -14% | -$163K |
|
963
Genuine Parts
GPC
$19.4B
| $996K | ﹤0.01% |
8,213
-2,066
| -20% | -$251K |
|
964
Celldex Therapeutics
CLDX
$1.52B
| $979K | ﹤0.01% |
48,099
| – | – |
|
965
Las Vegas Sands
LVS
$36.9B
| $972K | ﹤0.01% |
22,345
+3,159
| +16% | +$137K |
|
966
Equity Lifestyle Properties
ELS
$12B
| $950K | ﹤0.01% |
15,407
-2,025
| -12% | -$125K |
|
967
iShares MSCI Emerging Markets ETF
EEM
$19.2B
| $917K | ﹤0.01% |
19,000
-6,000
| -24% | -$289K |
|
968
MoonLake Immunotherapeutics
MLTX
$3.77B
| $915K | ﹤0.01% |
+19,390
| New | +$915K |
|
969
Alexandria Real Estate Equities
ARE
$14.5B
| $914K | ﹤0.01% |
12,589
-710,748
| -98% | -$51.6M |
|
970
Cogent Biosciences
COGT
$1.82B
| $896K | ﹤0.01% |
+124,728
| New | +$896K |
|
971
Constellation Brands
STZ
$26.2B
| $894K | ﹤0.01% |
+5,498
| New | +$894K |
|
972
POSCO
PKX
$15.5B
| $891K | ﹤0.01% |
18,381
+8,976
| +95% | +$435K |
|
973
Ecopetrol
EC
$18.7B
| $888K | ﹤0.01% |
+100,294
| New | +$888K |
|
974
Sarepta Therapeutics
SRPT
$1.96B
| $884K | ﹤0.01% |
51,704
-8,647
| -14% | -$148K |
|
975
WD-40
WDFC
$2.95B
| $875K | ﹤0.01% |
3,826
| – | – |
|